News

A new shot prevents HIV—and breathes new life into a stagnant biotech
Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...
NanoViricides Measles Drug Development Animal Study is Imminent
SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...
FDA approves a first-of-its-kind eye implant that slows vision loss in rare eye disease
For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have ...
EWN1d
Missed, misunderstood, and deadly: A Cape Town family’s heartbreak with hepatitis B
When Desmond Pedro discovered a strange hardness under his ribcage, he was just 30 and preparing for a fresh start on a ...
Targeting viral enzymes to strengthen brain immunity against HSV-1
Infections caused by herpes simplex virus type 1 (HSV-1) can lead to HSV-1 encephalitis—a rare but deadly condition that ...
gut.bmj4d
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
Only four patients (<1%) discontinued TVR for infection. The week 16 interim analysis of this EAP provided meaningful insights on the safety profile and on treatment efficacy of triple therapy with ...
The Lancet6d
Standardising HBV nomenclature: a call to action from the HBV Forum
The natural history of chronic hepatitis B virus (HBV) infection is driven by complex interactions among virological, host, ...
Medscape6d
GLP-1s Treat and Even Reverse Some Forms of Liver Disease
Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...
Rates of liver injuries rise in the U.S. as supplements grow in popularity
The liver is responsible for more than 500 functions in the human body, including filtering harmful substances from the blood ...
The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...
PNAS14d
Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity
In this study, we successfully established a pig model for chronic hepatitis E through oral treatment of pigs with a classical immunosuppressive drug regimen similar to that used for human organ ...